| Similar Articles |
|---|
 |
Pharmaceutical Executive
December 1, 2011 |
Europe's Transparency Directive Revisited The effect on pharma of the EU's Transparency Directive has been overly constraining, but will the mooted revisions offer any room to maneuver?   |
Pharmaceutical Executive
June 1, 2011 |
Are You Ready for the New China? The ability to act as a good corporate citizen and assert a useful role in national industrial policy on health is going to be essential to success in the new China. |
Pharmaceutical Executive
August 1, 2011
Ben Comer |
Is the 'Emerging Market' a Dated Concept? When it comes to the emerging markets, executing a few key elements of success are more important than ever. |
Pharmaceutical Executive
May 1, 2011 |
Seeing Through the Transparency Directive The EU is largely powerless when it comes to policies over pharma pricing and reimbursement. |
Pharmaceutical Executive
April 1, 2014 |
Whatever Happened To Faster Reimbursement For Generics In Europe? The plan to accelerate generic pricing and reimbursement has become another tragic European casualty. |
Pharmaceutical Executive
October 1, 2014 |
Eruptions on the Drug-Pricing Horizon in Europe An escalating political debate over pharma pricing and reimbursement nears the boiling point. |
Finance & Development
September 1, 2000 |
Supplement Czech Republic: Recent Developments and Current Outlook... Fall 2000 World Economic Outlook... International Capital Markets Report... Prague to Be Venue for 2000 IMF/World Bank Annual Meetings... |
Pharmaceutical Executive
September 1, 2012
Stan Bernard |
The Payer C Change: From Customers to Competitors "Payers have evolved to become powerful global contenders with pharma for increasingly limited funding of drug budgets." Understanding why and how this payer shift to dominance occurred is critical for pharmaceutical professionals in adjusting their business model. |
Pharmaceutical Executive
June 1, 2014
O'Connor et al. |
Challenges to the Specialty Business Model New constraints require new solutions. Innovative, value-based pricing models will be critical to securing reimbursement and continued market access of high-price drugs. |
Pharmaceutical Executive
November 1, 2008
Sarah Houlton |
Cash Flow Woes in EU In Europe, the wildly different attitudes toward healthcare across the different member states make for a complex pharmaceutical marketplace. |
| Knowledge@Wharton |
Czechmate, Or the Pitfalls of Rapid Privatization in Emerging Economies In his forthcoming book, Gerald McDermott offers a new explanation for why the Czech Republic and other emerging markets, which try to eliminate state involvement and undergo rapid mass privatization, may achieve only short-term or illusory economic success... |
Chemistry World
March 25, 2010
Rebecca Trager |
Big pharma scores in US healthcare reform President Obama has signed the biggest US healthcare reform since the 1960s, and although it is largely seen as a victory for the pharmaceutical industry, some analysts are characterising it as a 'double-edged sword'. |
Pharmaceutical Executive
September 1, 2011
Don Creighton |
Bridging the Hidden Hurdle in Cancer Cures Diagnostics can boast the efficacy of drug treatments, but delivering the promise depends on a predictable pathway to reimbursement. |
BusinessWeek
January 6, 2011
J. Webb et al. |
Joining the Euro: Poland and the Czechs Delay They were eager to join, but weakness in other nations makes it better for them to back off for now |
The Motley Fool
January 18, 2008
Brian Lawler |
Wrong-Way Regulators in Europe European Union regulators raided operations of multiple large pharmaceutical companies looking for antitrust and anticompetitive actions in both the branded and generic sectors. They're looking in the wrong places. |
Finance & Development
September 1, 2000
Roger Nord |
Central and Eastern Europe and the New Financial Architecture As the Central and Eastern European countries prepare to join the European Union, they are participating in worldwide efforts to strengthen the global economy... |
Reason
April 2001
Ronald Bailey |
Goddamn the Pusher Man Why does everybody seem to hate the pharmaceutical industry? |
The Motley Fool
November 30, 2010
Brian Orelli |
A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist. |
Pharmaceutical Executive
May 1, 2007
Humphrey Taylor |
Commentary: The Sky is Falling! Healthcare systems in the developed world are in crisis. A permanent one. Patients and their physicians will always want more treatments than governments or employers are willing to pay for. |
The Motley Fool
December 6, 2004
Brian Gorman |
Pill-Popping Nation Americans are using more prescription drugs. Unfortunately for big pharma investors, pharmaceutical companies' benefits from these trends are tempered by other factors. |
Finance & Development
September 1, 2002
Lipschitz et al. |
The Tosovsky Dilemma: Capital Surges in Transition Countries Transition countries that open themselves up to global capital markets are vulnerable to large and potentially erratic flows. Such flows should not be seen as one-off destabilizing events: they are intrinsic to the transition process and therefore need to be factored into policy formulation. |
The Motley Fool
May 21, 2009
Brian Orelli |
If You Can't Beat 'Em, Join 'Em: Pharma Goes Generic In the battle against generic rivals, it seems pharmaceutical companies would rather switch than fight. A pair of deals heralds Big Pharma's latest moves into the generic-drug world. See what Novartis and sanofi-aventis recently did. |
The Motley Fool
September 24, 2008
Brian Lawler |
Sanofi Gets the Golden Ring Sanofi-Aventis raises its bid and acquires Czech generic drugmaker Zentiva. |
Finance & Development
March 1, 2002 |
Book Reviews The End of Globalization: Lessons from the Great Depression by Harold James... Paradoxes of Prosperity: Why the New Capitalism Benefits All by Diane Coyle... Out of the Red: Building Capitalism and Democracy in Postcommunist Europe by Mitchell A. Orenstein... etc. |
IndustryWeek
April 1, 2002
Tom Mudd |
Hranice na Morava, Czech Republic Royal Philips Electronics and LG Electronics form an alliance and a factory to produce television picture tubes... |
Salon.com
September 27, 2000
Bruce Shapiro |
Prague dissent The International Monetary Fund and the World Bank hold their annual meeting in the Czech Republic -- a country that exemplifies growing European inequality. |
BusinessWeek
January 8, 2007
David Rocks |
Made In China--Er, Veliko Turnovo Chinese electronics manufacturer Sichuan Changhong is building a $30 million factory in Nymburk that will turn out 1 million flat-screen televisions a year when it swings into full production. |
Finance & Development
September 1, 2000
Janos Kornai |
Making the Transition to Private Ownership When the former centrally planned economies began the transition to a market economy one decade ago, there was strong disagreement on the best way to carry out ownership reform. 10 years into transition, experience has proved that organic development was the best strategy. |
Entrepreneur
April 2004
Joshua Kurlantzick |
New World Order The European Union will soon be a bigger cash cow. |
BusinessWeek
May 23, 2005
Ewing &Turek |
Hungry for Discounts, Not Delicacies East European shoppers are giving a cold shoulder to glitzy Western supermarkets. Meanwhile, Lidl opened its first Czech store in November, 2003 and now has more than 100 stores and nearly 5% of the $25.5 billion market. |
The Motley Fool
May 12, 2006
Stephen D. Simpson |
Stay Tuned to Central European Media There is long-term potential in the Czech market, as well as future acquisition prospects. However, the stock is not what one would consider exceptionally cheap. Investors, take note. |
Reason
December 2007
Michael C. Moynihan |
Flat Tax Fever European tax revolution: A flat tax revolution is under way in the former communist bloc. |
Military & Aerospace Electronics
April 2007
Annie Turner |
The View From Europe: Proposed U.S. Missile Shield in Europe Alarms Russians, Irks Some Europeans In an attempt to protect itself from the threat of intercontinental attacks, the U.S. has thoroughly alarmed the Russians and ensured that European nations have their own welfare, not the continent's, at heart. |
